mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

NCT07062536 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Biliary Cancer Metastatic

Interventions

DRUG: Oxaliplatin, 5FU, leucovorin
DRUG: Oxaliplatin, 5FU, leucovorin/Irinotecan , 5FU, leucovorin,

Sponsor

Seoul National University Bundang Hospital